Your browser is no longer supported. Please, upgrade your browser.
Settings
PTN Palatin Technologies, Inc. daily Stock Chart
PTN [NYSE]
Palatin Technologies, Inc.
Index- P/E5.78 EPS (ttm)0.14 Insider Own6.40% Shs Outstand233.11M Perf Week-1.04%
Market Cap184.44M Forward P/E- EPS next Y-0.04 Insider Trans0.83% Shs Float222.90M Perf Month-2.77%
Income37.00M PEG- EPS next Q-0.01 Inst Own21.40% Short Float10.78% Perf Quarter-13.48%
Sales60.40M P/S3.05 EPS this Y40.90% Inst Trans9.89% Short Ratio21.59 Perf Half Y-36.70%
Book/sh0.41 P/B1.93 EPS next Y20.00% ROA59.30% Target Price5.08 Perf Year2.65%
Cash/sh0.41 P/C1.91 EPS next 5Y- ROE63.20% 52W Range0.59 - 1.78 Perf YTD11.69%
Dividend- P/FCF- EPS past 5Y26.70% ROI35.50% 52W High-55.55% Beta1.68
Dividend %- Quick Ratio52.60 Sales past 5Y- Gross Margin- 52W Low34.10% ATR0.04
Employees18 Current Ratio52.60 Sales Q/Q182.20% Oper. Margin60.50% RSI (14)45.56 Volatility4.30% 4.36%
OptionableNo Debt/Eq0.00 EPS Q/Q30.30% Profit Margin61.20% Rel Volume0.72 Prev Close0.81
ShortableYes LT Debt/Eq0.00 EarningsNov 13 BMO Payout0.00% Avg Volume1.11M Price0.79
Recom- SMA20-0.99% SMA50-4.25% SMA200-22.13% Volume799,461 Change-2.75%
Jun-05-15Reiterated Canaccord Genuity Buy $4 → $6
Jan-12-15Reiterated ROTH Capital Buy $6 → $4
May-23-12Initiated Noble Financial Buy
Jan-23-07Initiated Next Generation Buy $5
Dec-03-19 11:44PM  Edited Transcript of PTN earnings conference call or presentation 13-Nov-19 4:00pm GMT Thomson Reuters StreetEvents
Nov-13-19 07:30AM  Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate Update PR Newswire
Nov-07-19 07:30AM  Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019 PR Newswire
Oct-31-19 11:53AM  Does Palatin Technologies (NYSEMKT:PTN) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-17-19 07:00AM  Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics PR Newswire
Oct-16-19 07:00AM  Vyleesi Phase 3 Data To Be Presented At The 13th European Society Of Gynecology Congress PR Newswire
Oct-08-19 02:06PM  How Many Palatin Technologies, Inc. (NYSEMKT:PTN) Shares Do Institutions Own? Simply Wall St.
Sep-17-19 05:41PM  Edited Transcript of PTN earnings conference call or presentation 12-Sep-19 3:00pm GMT Thomson Reuters StreetEvents
08:42AM  Should You Consider Palatin Technologies, Inc. (NYSEMKT:PTN)? Simply Wall St.
Sep-12-19 07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results PR Newswire
Sep-11-19 12:00PM  Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019 PR Newswire
Aug-19-19 10:44AM  Can You Imagine How Palatin Technologies's (NYSEMKT:PTN) Shareholders Feel About The 80% Share Price Increase? Simply Wall St.
Aug-16-19 10:42AM  Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks +6.07%
Aug-13-19 05:45PM  Palatin (PTN) Stock Sinks As Market Gains: What You Should Know Zacks
Aug-06-19 09:30AM  Is Palatin Technologies (PTN) Outperforming Other Medical Stocks This Year? Zacks +20.18%
07:00AM  Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference PR Newswire
Jul-26-19 05:45PM  Palatin (PTN) Stock Sinks As Market Gains: What You Should Know Zacks
Jul-19-19 05:45PM  Palatin (PTN) Gains As Market Dips: What You Should Know Zacks
Jul-17-19 09:30AM  Is Palatin Technologies (PTN) Outperforming Other Medical Stocks This Year? Zacks
Jul-12-19 12:51PM  Should You Worry About Palatin Technologies, Inc.'s (NYSEMKT:PTN) CEO Pay Cheque? Simply Wall St.
Jul-01-19 07:00AM  Palatin Technologies Provides Mid-Calendar Year Corporate Update PR Newswire -6.03%
Jun-25-19 03:49PM  Why Palatin Technologies Stock Dropped as Much as 21.5% Today Motley Fool -9.09%
Jun-24-19 04:45PM  Dow ekes out gain but fresh Iran sanctions drag broader stock market lower MarketWatch -9.70%
04:19PM  Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women TheStreet.com
10:54AM  Companies to Watch: Spotify downgraded, FDA signs off on Palatin drug, FedEx cuts prices Yahoo Finance
08:03AM  Palatin's stock rockets after FDA OK to market sexual desire disorder treatment MarketWatch
Jun-21-19 05:41PM  AMAG stock rallies on FDA approval for drug to increase women's sex drive MarketWatch
05:40PM  FDA Approves New Drug Application for Vyleesi (bremelanotide injection) PR Newswire
05:13PM  FDA approves drug for loss of female sexual desire Reuters
Jun-06-19 07:30AM  Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis PR Newswire -6.62%
May-20-19 03:48PM  Edited Transcript of PTN earnings conference call or presentation 9-May-19 3:00pm GMT Thomson Reuters StreetEvents +8.39%
May-14-19 08:17AM  What Does Poltronic S.A.'s (WSE:PTN) Balance Sheet Tell Us About It? Simply Wall St.
May-10-19 01:23PM  Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript Motley Fool
May-09-19 09:00AM  Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE
07:30AM  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
May-03-19 04:30PM  Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
Apr-15-19 09:27AM  What Kind Of Share Price Volatility Should You Expect For Palatin Technologies, Inc. (NYSEMKT:PTN)? Simply Wall St.
Apr-05-19 10:46AM  Palatin Technologies (PTN) in Focus: Stock Moves 5.7% Higher Zacks
Apr-04-19 07:30AM  Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases PR Newswire +5.74%
Mar-02-19 08:34AM  The Palatin Technologies Share Price Has Gained 103%, So Why Not Pay It Some Attention? Simply Wall St.
Feb-26-19 07:40AM  Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-12-19 05:20PM  Edited Transcript of PTN earnings conference call or presentation 12-Feb-19 4:00pm GMT Thomson Reuters StreetEvents
07:30AM  Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Feb-06-19 07:30AM  Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019 PR Newswire
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-18-18 12:06PM  Palatin Technologies, Inc. (PTN): Hedge Fund Sentiment Unchanged Insider Monkey
Dec-07-18 02:20PM  Edited Transcript of PTN earnings conference call or presentation 13-Nov-18 4:00pm GMT Thomson Reuters StreetEvents
Nov-27-18 07:40AM  Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-17-18 08:08AM  Heres What Palatin Technologies Incs (NYSEMKT:PTN) P/E Ratio Is Telling Us Simply Wall St.
Nov-13-18 08:11AM  What Kind Of Shareholders Own Palatin Technologies Inc (NYSEMKT:PTN)? Simply Wall St. -12.24%
07:30AM  Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Nov-11-18 08:51AM  Why Palatin Technologies Inc (NYSEMKT:PTN) Looks Like A Quality Company Simply Wall St.
Nov-08-18 07:30AM  Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist PR Newswire
Nov-07-18 04:15PM  Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on November 13, 2018 PR Newswire
Nov-05-18 10:30AM  Earnings Preview: Palatin (PTN) Q1 Earnings Expected to Decline Zacks
Oct-12-18 07:55AM  Recent Analysis Shows Booz Allen Hamilton Holding, j2 Global, Leidos, The Hain Celestial Group, Palatin Technologies, and Marsh & McLennan Companies Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-18-18 10:33PM  Edited Transcript of PTN earnings conference call or presentation 13-Sep-18 3:00pm GMT Thomson Reuters StreetEvents
Sep-13-18 08:01AM  Should You Be Tempted To Buy Poltronic SA (WSE:PTN) Because Of Its PE Ratio? Simply Wall St.
07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
07:08AM  Palatin Technologies Inc (NYSEMKT:PTN): Risks You Need To Consider Before Buying Simply Wall St.
Sep-07-18 04:00PM  Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018 PR Newswire
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-10-18 07:30AM  Analysis: Positioning to Benefit within FIS, Helix Energy, Palatin Technologies, NiSource, Service Corporation International, and Summit Hotel Properties Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jun-25-18 04:56PM  Palatin Technologies Added to Russell 3000® Index PR Newswire -8.48%
08:05AM  Today's Research Reports on Stocks to Watch: 22nd Century Group and Palatin Technologies ACCESSWIRE
Jun-06-18 07:30AM  Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks ACCESSWIRE
Jun-04-18 08:03AM  Palatin shares surge 9% premarket after FDA accepts for review treatment for HSDD MarketWatch
07:10AM  Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA PR Newswire
May-29-18 04:53AM  Was Poltronic SA.s (WSE:PTN) Earnings Growth Better Than The Industrys? Simply Wall St.
May-22-18 09:53PM  Edited Transcript of PTN earnings conference call or presentation 15-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-15-18 07:30AM  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 PR Newswire -7.63%
07:23AM  An Intrinsic Calculation For Palatin Technologies Inc (NYSEMKT:PTN) Shows Its 43% Undervalued Simply Wall St.
May-10-18 04:30PM  Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 PR Newswire
08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial New Research Emphasizes Economic Growth GlobeNewswire
May-09-18 07:30AM  Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts PR Newswire
May-06-18 10:02AM  Top NasdaqGS Undervalued Stock Simply Wall St.
Apr-19-18 11:50AM  Why Poltronic SA. (WSE:PTN) Delivered An Inferior ROE Compared To The Industry Simply Wall St.
Apr-06-18 02:43PM  HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold Benzinga
09:29AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Apr-03-18 07:30AM  Palatin Technologies Presents Preclinical Oral Formulation Data on PL-8177, An Investigational Melanocortin Receptor 1 Agonist for Inflammatory Bowel Diseases PR Newswire
Mar-29-18 08:27AM  Does Poltronic SA.s (WSE:PTN) PE Ratio Warrant A Buy? Simply Wall St.
06:47AM  With An ROE Of 242.93%, Has Palatin Technologies Incs (NYSEMKT:PTN) Management Done Well? Simply Wall St.
Mar-26-18 08:00AM  Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women PR Newswire
Mar-21-18 05:50PM  Does Palatin Technologies Incs (NYSEMKT:PTN) PE Ratio Signal A Buying Opportunity? Simply Wall St. +10.89%
Mar-17-18 10:02AM  Cheap Stocks To Watch Out For In March Simply Wall St.
Mar-08-18 07:50AM  Detailed Research: Economic Perspectives on HMS, Colfax, Fossil Group, Palatin Technologies, FIS, and Commercial Metals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-13-18 03:56PM  Edited Transcript of PTN earnings conference call or presentation 12-Feb-18 4:00pm GMT Thomson Reuters StreetEvents +5.76%
Feb-12-18 07:30AM  Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018 PR Newswire
Feb-07-18 04:00PM  Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018 PR Newswire
Feb-05-18 07:30AM  Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist PR Newswire
Jan-05-18 07:20AM  Blog Exposure - FDA Approved Palatins IND Application for PL-8177 as a Potential Treatment for Patients with Ulcerative Colitis ACCESSWIRE
Jan-03-18 07:30AM  Palatin Technologies, Inc. Announces FDA Clearance of Investigational New Drug (IND) Application for PL-8177 For Ulcerative Colitis PR Newswire +10.71%
Dec-26-17 08:02AM  Top Cheap Stocks This Week Simply Wall St.
Nov-22-17 02:15PM  Edited Transcript of PTN earnings conference call or presentation 13-Nov-17 4:00pm GMT Thomson Reuters StreetEvents
Nov-21-17 07:30AM  Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea PR Newswire
Nov-16-17 08:03AM  November Top Cheap Stock To Invest In Simply Wall St.
Nov-14-17 08:10AM  Recent Analysis Shows Nielsen Holdings, Palatin Technologies, MasTec, Iconix Brand, Eversource Energy, and Booz Allen Hamilton Holding Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-13-17 07:30AM  Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017 PR Newswire
Nov-08-17 04:00PM  Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017 PR Newswire
Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific product candidates for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist, which has completed Phase III trial for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor 1 (MCr) agonist peptide that has completed Phase I clinical trial for inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease. Further, it is involved in developing MC4r agonist peptide and small molecule for the treatment of rare genetic metabolic and obesity disorders. Additionally, the company engages in the development of PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, a dual NPR-A and NPR-C agonist to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hull Joseph StanleyDirectorAug 05Buy0.78800627520,799Aug 07 04:30 PM
SPANA CARLPresident and CEOAug 02Buy0.8620,00017,2605,993,852Aug 05 04:12 PM
WILLS STEPHEN TExecutive VP and CFO/COOAug 01Buy0.8750,00043,2505,314,239Aug 05 04:18 PM
DEVEER ROBERT K JRDirectorAug 01Buy0.8622,58019,419568,139Aug 05 04:14 PM
SPANA CARLPresident and CEOAug 01Buy0.8630,00025,8595,973,852Aug 05 04:12 PM